当前位置: X-MOL 学术Catheter. Cardiovasc. Interv. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Safety, feasibility, and incremental value of ultralow and zero contrast PCI in an all-comers registry
Catheterization & Cardiovascular Interventions ( IF 2.1 ) Pub Date : 2024-09-02 , DOI: 10.1002/ccd.31214
Abhishek C Sawant 1 , Nachiket Patel 1 , Ashish Pershad 1
Affiliation  

Patients with chronic kidney disease and CAD have been denied revascularization because of fear of precipitating acute renal failure from contrast exposure. Skepticism on whether Ultra-Low contrast percutaneous coronary intervention (PCI) or Zero contrast PCI (ULC/ZC PCI) can be safely performed has limited its adoption.

中文翻译:


超低和零对比度 PCI 在全能者登记中的安全性、可行性和增量价值



慢性肾病和 CAD 患者被拒绝进行血运重建,因为担心造影剂暴露会诱发急性肾衰竭。对超低对比度经皮冠状动脉介入治疗 (PCI) 或零对比 PCI (ULC/ZC PCI) 是否可以安全进行的怀疑限制了其采用。
更新日期:2024-09-02
down
wechat
bug